Preliminary studies on the development of IgA-loaded chitosan–dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens

References

• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004; 100: 5–28
   PubMed Web of Science ®Google Scholar
• Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 2006; 111: 107–16
   PubMed Web of Science ®Google Scholar
• Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, Huckriede A, Crommelin DJA, Jiskoot W. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model. Vaccine 2007; 25: 144–53
   PubMed Web of Science ®Google Scholar
• Borges O, Cordeiro-da-Silva A, Romeijn SG, Amidi M, de Sousa A, Borchard G, Junginger HE. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Control Release 2006; 114: 348–58
   PubMed Web of Science ®Google Scholar
• Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles. Eur J Pharm Sci 2007; 32: 278–90
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25: 5467–84
   PubMed Web of Science ®Google Scholar
• Brayden DJ, Jepson MA, Baird AW. Keynote review: Intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov Today 2005; 10: 1145–57
   PubMed Web of Science ®Google Scholar
• Burns DL, Kenimer JG, Manclark CR. Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun 1987; 55: 24–8
   Google Scholar
• Chen Y, Mohanraj V, Parkin J. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Int J Pept Res Ther 2003; 10: 621–9
   Google Scholar
• Chen Y, Mohanraj VJ, Wang F, Benson HA. Designing chitosan-dextran sulfate nanoparticles using charge ratios. AAPS PharmSciTech 2007; 8: E98
   PubMed Web of Science ®Google Scholar
• Chen Y, Siddalingappa B, Chan PH, Benson HA. Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin. Biopolymers 2008; 90: 663–70
   PubMed Web of Science ®Google Scholar
• Corbel MJ, Xing DK. Toxicity and potency evaluation of pertussis vaccines. Expert Rev Vaccines 2004; 3: 89–101
   PubMedGoogle Scholar
• Corthesy B. Roundtrip ticket for secretory IgA: Role in mucosal homeostasis?. J Immunol 2007; 178: 27–32
   PubMed Web of Science ®Google Scholar
• Davis SS. Nasal vaccines. Adv Drug Delivery Rev 2001; 51: 21–42
   PubMed Web of Science ®Google Scholar
• Drogoz A, David L, Rochas C, Domard A, Delair T. Polyelectrolyte complexes from polysaccharides: Formation and stoichiometry monitoring. Langmuir 2007; 23: 10950–8
   PubMed Web of Science ®Google Scholar
• Favre L, Spertini F, Corthesy B. Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses. J Immunol 2005; 175: 2793–800
   PubMed Web of Science ®Google Scholar
• Fowler S, Byron O, Jumel K, Xing D, Corbel MJ, Bolgiano B. Novel configurations of high molecular weight species of the pertussis toxin vaccine component. Vaccine 2003; 21: 2678–88
   PubMed Web of Science ®Google Scholar
• Fujimura Y, Akisada T, Harada T, Haruma K. Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue. Med Mol Morphol 2006; 39: 181–6
   PubMed Web of Science ®Google Scholar
• Gan Q, Wang T, Cochrane C, Mccarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B: Biointerfaces 2005; 44: 65–73
   PubMed Web of Science ®Google Scholar
• Hewlett EL, Sauer KT, Myers GA, Cowell JL, Guerrant RL. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun 1983; 40: 1198–203
   PubMed Web of Science ®Google Scholar
• Ibsen PH. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. Vaccine 1996; 14: 359–68
   PubMed Web of Science ®Google Scholar
• Illum L. Nanoparticulate systems for nasal delivery of drugs: A real improvement over simple systems?. J Pharm Sci 2007; 96: 473–83
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 2006; 24: 4201–11
   PubMed Web of Science ®Google Scholar
• Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 2001; 47: 83–97
   PubMed Web of Science ®Google Scholar
• Kabanov VA, Zezin AB. A new class of complex water-soluble polyelectrolytes. Die Makromol Chem 1984; 6: 259–76
   Google Scholar
• Kallenius G, Pawlowski A, Brandtzaeg P, Svenson S. Should a new tuberculosis vaccine be administered intranasally?. Tuberculosis 2007; 87: 257–66
   PubMed Web of Science ®Google Scholar
• Kato T. A study of secretory immunoglobulin A on membranous epithelial cells (M cells) and adjacent absorptive cells of rabbit Peyer's patches. Gastroenterol Jpn 1990; 25: 15–23
   PubMedGoogle Scholar
• Kiyono H, Fukuyama S. NALT-versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004; 4: 699–710
   PubMed Web of Science ®Google Scholar
• Ma Z, Yeoh HH, Lim LY. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci 2002; 91: 1396–404
   PubMed Web of Science ®Google Scholar
• Mantis NJ, Cheung MC, Chintalacharuvu KR, Rey J, Corthesy B, Neutra MR. Selective adherence of IgA to murine Peyer's patch M cells: Evidence for a novel IgA receptor. J Immunol 2002; 169: 1844–51
   PubMed Web of Science ®Google Scholar
• Mestecky J, Blumberg RS, Kiyono H, Mcghee JR. The mucosal immune system. Fundamental immunology5th, WE Paul. Lippincott Williams & Wilkins, Philadelphia, PA 2003; 965–1020
   Google Scholar
• Mincheva R, Bougard F, Paneva D, Vachaudez M, Manolova N, Rashkov I, Dubois P. Natural polyampholyte-based core-shell nanoparticles with N-carboxyethylchitosan-containing core and poly(ethylene oxide) shell. Biomacromolecules 2009; 10: 838–44
   PubMed Web of Science ®Google Scholar
• Munoz JJ, Arai H, Cole RL. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun 1981; 32: 243–50
   PubMed Web of Science ®Google Scholar
• Nencioni L, Pizza MG, Volpini G, de Magistris MT, Giovannoni F, Rappuoli R. Properties of the B oligomer of pertussis toxin. Infect Immun 1991; 59: 4732–4
   PubMedGoogle Scholar
• Nochi T, Yuki Y, Matsumura A, Mejima M, Terahara K, Kim DY, Fukuyama S, Iwatsuki-Horimoto K, Kawaoka Y, Kohda T, et al. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 2007; 204: 2789–96
   PubMed Web of Science ®Google Scholar
• Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, Hao JS, Cui FD. Bioadhesive polysaccharide in protein delivery system: Chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002; 249: 139–47
   PubMed Web of Science ®Google Scholar
• Rabilloud T, Brodard V, Peltre G, Righetti PG, Ettori C. Modified silver staining for immobilized pH gradients. Electrophoresis 1992; 13: 264–6
   PubMed Web of Science ®Google Scholar
• Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells with biomaterials: Developing the next generation of vaccines. Trends Immunol 2006; 27: 573–9
   PubMed Web of Science ®Google Scholar
• Roy MJ, Varvayanis M. Development of dome epithelium in gut-associated lymphoid tissues: Association of IgA with M cells. Cell Tissue Res 1987; 248: 645–51
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D. Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B: Biointerfaces 2006; 53: 193–202
   PubMed Web of Science ®Google Scholar
• Schatz C, Lucas JM, Viton C, Domard A, Pichot C, Delair T. Formation and properties of positively charged colloids based on polyelectrolyte complexes of biopolymers. Langmuir 2004; 20: 7766–78
   PubMed Web of Science ®Google Scholar
• Sharma S, Mukkur TK, Benson HA, Chen Y. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems. J Pharm Sci 2009; 98: 812–43
   PubMed Web of Science ®Google Scholar
• Sogias IA, Williams AC, Khutoryanskiy VV. Why is chitosan mucoadhesive?. Biomacromolecules 2008; 9: 1837–42
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W, Limpeanchob N. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int J Pharm 2007; 329: 142–9
   PubMed Web of Science ®Google Scholar
• WHO. Pertussis vaccines WHO position paper. Weekly epidemiological record. World Health Organization, Geneva 2005
   Google Scholar
• Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003; 250: 215–26
   PubMed Web of Science ®Google Scholar
• Zhou F, Kraehenbuhl JP, Neutra MR. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine 1995; 13: 637–44
   PubMed Web of Science ®Google Scholar